Jonathan S. Sussman MD
Adult Congenital Heart Disease, Cardiac Electrophysiology
Electrophysiology Associates
Join to View Full Profile
100 Madison AveBox 5Morristown, NJ 07962
Phone+1 973-971-4261
Fax+1 973-290-7253
Dr. Sussman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Clinical Cardiac Electrophysiology, 2005 - 2006- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2002 - 2005
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
Albert Einstein College of MedicineClass of 1998
Certifications & Licensure
NJ State Medical License 2006 - 2027
PA State Medical License 1999 - 2008
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Clinical Cardiac Electrophysiology
National Board of Physicians and Surgeons Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study Start of enrollment: 2012 Apr 01
- nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 1 citationsDiagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.Omar Elghawy, Reema Patel, Adam Barsouk, Joe Puthumana, Jason Xu
Journal of Oncology Pharmacy Practice. 2025-06-01 - Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.Haley Newman, Shawn H R Lee, Petri Pölönen, Rawan Shraim, Yimei Li
Blood Cancer Discovery. 2025-05-28 - Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy.Omar Elghawy, Adam Barsouk, Lauren Reed-Guy, Margaret Stalker, Jonathan Sussman
Clinical Lung Cancer. 2025-03-01
Press Mentions
Cardiac Care: Atlantic Health SystemFebruary 21st, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
